Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
Lemmy is its own cult. Weight mentioned in the headline and every comment is about their zero science “worked for me” aproach to weight loss and then claiming its universal and drugs bad. Not a single comment talking about how this research has found a medicine for diabetes treatment that can be used for people having bad reactions to standard one, and the fact that thats really cool